table of content
1 Introduction to Research & Analysis Reports
1.1 Respiratory Syncytial Virus Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Respiratory Syncytial Virus Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Respiratory Syncytial Virus Vaccines Overall Market Size
2.1 Global Respiratory Syncytial Virus Vaccines Market Size: 2022 VS 2029
2.2 Global Respiratory Syncytial Virus Vaccines Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Respiratory Syncytial Virus Vaccines Players in Global Market
3.2 Top Global Respiratory Syncytial Virus Vaccines Companies Ranked by Revenue
3.3 Global Respiratory Syncytial Virus Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Respiratory Syncytial Virus Vaccines Companies in Global Market, by Revenue in 2022
3.5 Global Companies Respiratory Syncytial Virus Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Respiratory Syncytial Virus Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Respiratory Syncytial Virus Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Respiratory Syncytial Virus Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Respiratory Syncytial Virus Vaccines Market Size Markets, 2022 & 2029
4.1.2 Palivizumab
4.1.3 RSVpreF PF06928316
4.1.4 RSVPreF3 OA (GSK3844766A)
4.1.5 mRNA-1345
4.1.6 Janssen RSV Vaccine
4.1.7 ResVax
4.1.8 Nirsevimab (MEDI8897)
4.1.9 MVA-BN RSV
4.2 By Type - Global Respiratory Syncytial Virus Vaccines Revenue & Forecasts
4.2.1 By Type - Global Respiratory Syncytial Virus Vaccines Revenue, 2018-2023
4.2.2 By Type - Global Respiratory Syncytial Virus Vaccines Revenue, 2024-2029
4.2.3 By Type - Global Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Respiratory Syncytial Virus Vaccines Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Research Institute
5.2 By Application - Global Respiratory Syncytial Virus Vaccines Revenue & Forecasts
5.2.1 By Application - Global Respiratory Syncytial Virus Vaccines Revenue, 2018-2023
5.2.2 By Application - Global Respiratory Syncytial Virus Vaccines Revenue, 2024-2029
5.2.3 By Application - Global Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Respiratory Syncytial Virus Vaccines Market Size, 2022 & 2029
6.2 By Region - Global Respiratory Syncytial Virus Vaccines Revenue & Forecasts
6.2.1 By Region - Global Respiratory Syncytial Virus Vaccines Revenue, 2018-2023
6.2.2 By Region - Global Respiratory Syncytial Virus Vaccines Revenue, 2024-2029
6.2.3 By Region - Global Respiratory Syncytial Virus Vaccines Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Respiratory Syncytial Virus Vaccines Revenue, 2018-2029
6.3.2 US Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.3.3 Canada Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.3.4 Mexico Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Respiratory Syncytial Virus Vaccines Revenue, 2018-2029
6.4.2 Germany Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.3 France Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.4 U.K. Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.5 Italy Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.6 Russia Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.7 Nordic Countries Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.4.8 Benelux Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Respiratory Syncytial Virus Vaccines Revenue, 2018-2029
6.5.2 China Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.5.3 Japan Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.5.4 South Korea Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.5.5 Southeast Asia Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.5.6 India Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Respiratory Syncytial Virus Vaccines Revenue, 2018-2029
6.6.2 Brazil Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.6.3 Argentina Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Respiratory Syncytial Virus Vaccines Revenue, 2018-2029
6.7.2 Turkey Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.7.3 Israel Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.7.4 Saudi Arabia Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
6.7.5 UAE Respiratory Syncytial Virus Vaccines Market Size, 2018-2029
7 Respiratory Syncytial Virus Vaccines Companies Profiles
7.1 Pfizer Inc.Pfizer Inc.
7.1.1 Pfizer Inc.Pfizer Inc. Company Summary
7.1.2 Pfizer Inc.Pfizer Inc. Business Overview
7.1.3 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Major Product Offerings
7.1.4 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.1.5 Pfizer Inc.Pfizer Inc. Key News & Latest Developments
7.2 Sanofi
7.2.1 Sanofi Company Summary
7.2.2 Sanofi Business Overview
7.2.3 Sanofi Respiratory Syncytial Virus Vaccines Major Product Offerings
7.2.4 Sanofi Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.2.5 Sanofi Key News & Latest Developments
7.3 Merck Sharp & Dohme
7.3.1 Merck Sharp & Dohme Company Summary
7.3.2 Merck Sharp & Dohme Business Overview
7.3.3 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Major Product Offerings
7.3.4 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.3.5 Merck Sharp & Dohme Key News & Latest Developments
7.4 GlaxoSmithKline
7.4.1 GlaxoSmithKline Company Summary
7.4.2 GlaxoSmithKline Business Overview
7.4.3 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Major Product Offerings
7.4.4 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.4.5 GlaxoSmithKline Key News & Latest Developments
7.5 SOBI
7.5.1 SOBI Company Summary
7.5.2 SOBI Business Overview
7.5.3 SOBI Respiratory Syncytial Virus Vaccines Major Product Offerings
7.5.4 SOBI Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.5.5 SOBI Key News & Latest Developments
7.6 Johnson & Johnson
7.6.1 Johnson & Johnson Company Summary
7.6.2 Johnson & Johnson Business Overview
7.6.3 Johnson & Johnson Respiratory Syncytial Virus Vaccines Major Product Offerings
7.6.4 Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.6.5 Johnson & Johnson Key News & Latest Developments
7.7 Bavarian Nordic
7.7.1 Bavarian Nordic Company Summary
7.7.2 Bavarian Nordic Business Overview
7.7.3 Bavarian Nordic Respiratory Syncytial Virus Vaccines Major Product Offerings
7.7.4 Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.7.5 Bavarian Nordic Key News & Latest Developments
7.8 Novavax
7.8.1 Novavax Company Summary
7.8.2 Novavax Business Overview
7.8.3 Novavax Respiratory Syncytial Virus Vaccines Major Product Offerings
7.8.4 Novavax Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.8.5 Novavax Key News & Latest Developments
7.9 AstraZeneca
7.9.1 AstraZeneca Company Summary
7.9.2 AstraZeneca Business Overview
7.9.3 AstraZeneca Respiratory Syncytial Virus Vaccines Major Product Offerings
7.9.4 AstraZeneca Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.9.5 AstraZeneca Key News & Latest Developments
7.10 Moderna
7.10.1 Moderna Company Summary
7.10.2 Moderna Business Overview
7.10.3 Moderna Respiratory Syncytial Virus Vaccines Major Product Offerings
7.10.4 Moderna Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.10.5 Moderna Key News & Latest Developments
7.11 Codagenix
7.11.1 Codagenix Company Summary
7.11.2 Codagenix Business Overview
7.11.3 Codagenix Respiratory Syncytial Virus Vaccines Major Product Offerings
7.11.4 Codagenix Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.11.5 Codagenix Key News & Latest Developments
7.12 Intravacc
7.12.1 Intravacc Company Summary
7.12.2 Intravacc Business Overview
7.12.3 Intravacc Respiratory Syncytial Virus Vaccines Major Product Offerings
7.12.4 Intravacc Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.12.5 Intravacc Key News & Latest Developments
7.13 Alphavax
7.13.1 Alphavax Company Summary
7.13.2 Alphavax Business Overview
7.13.3 Alphavax Respiratory Syncytial Virus Vaccines Major Product Offerings
7.13.4 Alphavax Respiratory Syncytial Virus Vaccines Revenue in Global Market (2018-2023)
7.13.5 Alphavax Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
